First National Advisers’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.03M Buy
11,981
+129
+1% +$11.3K 0.14% 123
2026
Q1
$1.07M Buy
11,852
+7,367
+164% +$676K 0.16% 117
2025
Q4
$403K Buy
+4,485
New +$425K 0.06% 181

Other funds holding ZBH

First National Advisers's ZBH Position: Q2 2026 in Review

First National Advisers increased its Zimmer Biomet (ZBH) stake by 1.1% in Q2 2026, buying an estimated $11.3K and bringing the position to 11,981 shares worth $1.03M. The position accounts for 0.14% of the portfolio, ranked #123.

First National Advisers first reported a position in ZBH in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.07M in Q1 2026. 150 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • First National Advisers held 11,981 shares of Zimmer Biomet worth $1.03M as of Q2 2026.
  • First National Advisers bought 129 Zimmer Biomet shares in Q2 2026, an estimated $11.3K.
  • Zimmer Biomet made up 0.14% of First National Advisers's portfolio in Q2 2026, its #123 holding.
  • First National Advisers first reported a position in Zimmer Biomet in Q4 2025 and has held it in 3 quarters since.
  • First National Advisers's Zimmer Biomet position peaked at $1.07M in Q1 2026.
  • 150 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on First National Advisers's 13F filing for Q2 2026, filed 21 Jul 2026.